This article needs additional citations for verification. (December 2012) (Learn how and when to remove this template message)
Chemical antagonist impede the normal function of a system. They function to invert the effects of other molecules. The effects of antagonists can be seen after they have encountered an Agonist, and as a result, the effects of the agonist is neutralized. Antagonists such as Dopamine Antagonist slow down movement in lab rats. Although they hinder the joining of enzymes to substrates, Antagonists can be beneficial. For example, not only do Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme (ACE) inhibitors work to lower blood pressure, but they also counter the effects of renal disease in diabetic and non-diabetic patients. Chelating agents, such as Calcium Di sodium Defeated, fall in the category of antagonists and operate to minimize the lethal effects of heavy metals such as Mercury or Lead.
In chemistry, antagonism is a phenomenon wherein two or more agents in combination have an overall effect that is less than the sum of their individual effects.
The word is most commonly used in this context in biochemistry and toxicology: interference in the physiological action of a chemical substance by another having a similar structure. For instance, a receptor antagonist is an agent that reduces the response that a ligand produces when the receptor antagonist binds to a receptor on a cell. An example of this is the interleukin-1 receptor antagonist. The opposite of antagonism is synergy. It is a negative type of synergism.
- Claussen, C. M.; Witte, L. J.; Dafny, N (2015). "Single exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methamphetamine effect". Journal of Experimental Pharmacology. 7: 1–9. doi:10.2147/JEP.S75300. PMC . PMID 27186140.
- Lewis, Edmund J.; Hunsicker, Lawrence G.; Clarke, William R.; Berl, Tomas; Pohl, Marc A.; Lewis, Julia B.; Ritz, Eberhard; Atkins, Robert C.; Rohde, Richard; Raz, Itamar (2001). "Renoprotective Effect of the Angioplasty-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes". New England Journal of Medicine. 345 (12): 851. doi:10.1056/NEJMoa011303. PMID 11565517.
- Kalaitzidis, R; Bakris, G. L. (2009). "Effects of angiotensin II receptor blockers on diabetic nephropathy". Journal of Hypertension. 27 (5): S15–21. doi:10.1097/01.hjh.0000357904.71080.7d. PMID 19587550.
- Peyrat-Maillard, M. N.; Cuvelier, M. E.; Berset, C. (2003). "Antioxidant activity of phenolic compounds in 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced oxidation: Synergistic and antagonistic effects". Journal of the American Oil Chemists' Society. 80 (10): 1007. doi:10.1007/s11746-003-0812-z.
|This chemistry-related article is a stub. You can help Wikipedia by expanding it.|
|This Toxicology-related article is a stub. You can help Wikipedia by expanding it.|